- We asked venture capitalists what startups they wish they could fund.
- Many had an interest in finding companies that could tackle neurodegenerative diseases, including Alzheimer’s, though not much has caught their eyes so far.
- “The problem is we don’t know enough about how the disease works to really invest in one drug or another,” Alexis Borisy, a partner at Third Rock Ventures told Business Insider.
- VCs are also interested in finding ways to treat cancer that come with fewer side effects, as well as more targeted forms of cancer immunotherapy.
On a recent trip to San Francisco, we asked venture capitalists read more >>>